The molecular landscape of pancreatic ductal adenocarcinoma.

Sivapalan, L; Kocher, H M; Ross-Adams, H; Chelala, C

Sivapalan, L; Kocher, H M; Ross-Adams, H; Chelala, C.

Afiliação

Sivapalan L; Bioinformatics Unit, Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK.
Kocher HM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, UK.
Ross-Adams H; Bioinformatics Unit, Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK. Electronic address: h.ross-adams@qmul.ac.uk.
Chelala C; Bioinformatics Unit, Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK. Electronic address: c.chelala@qmul.ac.uk.

Pancreatology ; 22(7): 925-936, 2022 Nov.

Article em En | MEDLINE | ID: mdl-35927150

Assuntos

Carcinoma Ductal Pancreático; Neoplasias Pancreáticas; Humanos; Carcinoma Ductal Pancreático/diagnóstico; Carcinoma Ductal Pancreático/genética; Carcinoma Ductal Pancreático/patologia; Neoplasias Pancreáticas/diagnóstico; Neoplasias Pancreáticas/genética; Neoplasias Pancreáticas/patologia; Prognóstico; Genômica; Biomarcadores Tumorais/genética; Neoplasias Pancreáticas

Palavras-chave

Biomarker; Circulating tumour DNA; Molecular subtypes; PDAC; Somatic mutations

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google